Additional 8% Tariff Threat For Pharma, Says Trump

US President Donald Trump warned drugmakers of an additional 5-8% tariff if no deal is reached, following his recent 100% tariff announcement on patented imports. Firms with US plants are exempt. Pfizer struck a deal, investing $70 billion in R&D and domestic manufacturing, gaining a three-year grace period while offering discounted drugs via TrumpRx.